Top Key Companies for Sexually Transmitted Diseases (STD) Testing Market: Lonza, Cepheid, ELITechGroup, Abbott, Affymetrix, Bio-Rad, DiaSorin, bioMerieux, Eiken Chemical, Becton Dickinson, Siemens Healthineers, GSK Biologicals.
Global Sexually Transmitted Diseases (STD) Testing Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Sexually Transmitted Diseases (STD) Testing Market Overview And Scope:
The Global Sexually Transmitted Diseases (STD) Testing Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Sexually Transmitted Diseases (STD) Testing utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Global Sexually Transmitted Diseases (STD) Testing Market Segmentation
By Type, Sexually Transmitted Diseases (STD) Testing market has been segmented into:
Chlamydia
Syphilis
Gonorrhea
Herpes Simplex Virus
Human Papilloma Virus
Human Immunodeficiency Virus
Others
By Application, Sexually Transmitted Diseases (STD) Testing market has been segmented into:
Hospitals
Commercial/Private Labs
Physician Offices
Public Health Labs
Regional Analysis of Sexually Transmitted Diseases (STD) Testing Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Sexually Transmitted Diseases (STD) Testing Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Sexually Transmitted Diseases (STD) Testing market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Sexually Transmitted Diseases (STD) Testing market.
Top Key Companies Covered in Sexually Transmitted Diseases (STD) Testing market are:
Lonza
Cepheid
ELITechGroup
Abbott
Affymetrix
Bio-Rad
DiaSorin
bioMerieux
Eiken Chemical
Becton Dickinson
Siemens Healthineers
GSK Biologicals
Key Questions answered in the Sexually Transmitted Diseases (STD) Testing Market Report:
1. What is the expected Sexually Transmitted Diseases (STD) Testing Market size during the forecast period, 2025-2032?
2. Which region is the largest market for the Sexually Transmitted Diseases (STD) Testing Market?
3. What is the expected future scenario and the revenue generated by different regions and countries in the Sexually Transmitted Diseases (STD) Testing Market, such as North America, Europe, AsiaPacific & Japan, China, U.K., South America, and Middle East and Africa?
4. What is the competitive strength of the key players in the Sexually Transmitted Diseases (STD) Testing Market on the basis of the analysis of their recent developments, product offerings, and regional presence?
5. Where do the key Sexually Transmitted Diseases (STD) Testing companies lie in their competitive benchmarking compared to the factors of market coverage and market potential?
6. How are the adoption scenario, related opportunities, and challenges impacting the Sexually Transmitted Diseases (STD) Testing Markets?
7. How is the funding and investment landscape in the Sexually Transmitted Diseases (STD) Testing Market?
8. Which are the leading consortiums and associations in the Sexually Transmitted Diseases (STD) Testing Market, and what is their role in the market?
Research Methodology for Sexually Transmitted Diseases (STD) Testing Market Report:
The report presents a detailed assessment of the Sexually Transmitted Diseases (STD) Testing Market, along with qualitative inputs and insights from Company. This research study involved the extensive use of both primary and secondary sources.Various factors affecting the industry were studied to identify the segmentation types; industry trends; key players; competitive landscape of different products and services provided by separate market players;key market dynamics, such as drivers, restraints, opportunities, challenges, and industry trends; and key player strategies. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights.Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Sexually Transmitted Diseases (STD) Testing Market by Type
5.1 Sexually Transmitted Diseases (STD) Testing Market Overview Snapshot and Growth Engine
5.2 Sexually Transmitted Diseases (STD) Testing Market Overview
5.3 Chlamydia
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Chlamydia: Geographic Segmentation
5.4 Syphilis
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Syphilis: Geographic Segmentation
5.5 Gonorrhea
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Gonorrhea: Geographic Segmentation
5.6 Herpes Simplex Virus
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Herpes Simplex Virus: Geographic Segmentation
5.7 Human Papilloma Virus
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Human Papilloma Virus: Geographic Segmentation
5.8 Human Immunodeficiency Virus
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size (2017-2032F)
5.8.3 Key Market Trends, Growth Factors and Opportunities
5.8.4 Human Immunodeficiency Virus: Geographic Segmentation
5.9 Others
5.9.1 Introduction and Market Overview
5.9.2 Historic and Forecasted Market Size (2017-2032F)
5.9.3 Key Market Trends, Growth Factors and Opportunities
5.9.4 Others: Geographic Segmentation
Chapter 6: Sexually Transmitted Diseases (STD) Testing Market by Application
6.1 Sexually Transmitted Diseases (STD) Testing Market Overview Snapshot and Growth Engine
6.2 Sexually Transmitted Diseases (STD) Testing Market Overview
6.3 Hospitals
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospitals: Geographic Segmentation
6.4 Commercial/Private Labs
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Commercial/Private Labs: Geographic Segmentation
6.5 Physician Offices
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Physician Offices: Geographic Segmentation
6.6 Public Health Labs
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Public Health Labs: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Sexually Transmitted Diseases (STD) Testing Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Sexually Transmitted Diseases (STD) Testing Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Sexually Transmitted Diseases (STD) Testing Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 LONZA
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 CEPHEID
7.4 ELITECHGROUP
7.5 ABBOTT
7.6 AFFYMETRIX
7.7 BIO-RAD
7.8 DIASORIN
7.9 BIOMERIEUX
7.10 EIKEN CHEMICAL
7.11 BECTON DICKINSON
7.12 SIEMENS HEALTHINEERS
7.13 GSK BIOLOGICALS
Chapter 8: Global Sexually Transmitted Diseases (STD) Testing Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Chlamydia
8.2.2 Syphilis
8.2.3 Gonorrhea
8.2.4 Herpes Simplex Virus
8.2.5 Human Papilloma Virus
8.2.6 Human Immunodeficiency Virus
8.2.7 Others
8.3 Historic and Forecasted Market Size By Application
8.3.1 Hospitals
8.3.2 Commercial/Private Labs
8.3.3 Physician Offices
8.3.4 Public Health Labs
Chapter 9: North America Sexually Transmitted Diseases (STD) Testing Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Chlamydia
9.4.2 Syphilis
9.4.3 Gonorrhea
9.4.4 Herpes Simplex Virus
9.4.5 Human Papilloma Virus
9.4.6 Human Immunodeficiency Virus
9.4.7 Others
9.5 Historic and Forecasted Market Size By Application
9.5.1 Hospitals
9.5.2 Commercial/Private Labs
9.5.3 Physician Offices
9.5.4 Public Health Labs
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Sexually Transmitted Diseases (STD) Testing Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Chlamydia
10.4.2 Syphilis
10.4.3 Gonorrhea
10.4.4 Herpes Simplex Virus
10.4.5 Human Papilloma Virus
10.4.6 Human Immunodeficiency Virus
10.4.7 Others
10.5 Historic and Forecasted Market Size By Application
10.5.1 Hospitals
10.5.2 Commercial/Private Labs
10.5.3 Physician Offices
10.5.4 Public Health Labs
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Sexually Transmitted Diseases (STD) Testing Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Chlamydia
11.4.2 Syphilis
11.4.3 Gonorrhea
11.4.4 Herpes Simplex Virus
11.4.5 Human Papilloma Virus
11.4.6 Human Immunodeficiency Virus
11.4.7 Others
11.5 Historic and Forecasted Market Size By Application
11.5.1 Hospitals
11.5.2 Commercial/Private Labs
11.5.3 Physician Offices
11.5.4 Public Health Labs
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Sexually Transmitted Diseases (STD) Testing Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Chlamydia
12.4.2 Syphilis
12.4.3 Gonorrhea
12.4.4 Herpes Simplex Virus
12.4.5 Human Papilloma Virus
12.4.6 Human Immunodeficiency Virus
12.4.7 Others
12.5 Historic and Forecasted Market Size By Application
12.5.1 Hospitals
12.5.2 Commercial/Private Labs
12.5.3 Physician Offices
12.5.4 Public Health Labs
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Chlamydia
13.4.2 Syphilis
13.4.3 Gonorrhea
13.4.4 Herpes Simplex Virus
13.4.5 Human Papilloma Virus
13.4.6 Human Immunodeficiency Virus
13.4.7 Others
13.5 Historic and Forecasted Market Size By Application
13.5.1 Hospitals
13.5.2 Commercial/Private Labs
13.5.3 Physician Offices
13.5.4 Public Health Labs
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Sexually Transmitted Diseases (STD) Testing Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Chlamydia
14.4.2 Syphilis
14.4.3 Gonorrhea
14.4.4 Herpes Simplex Virus
14.4.5 Human Papilloma Virus
14.4.6 Human Immunodeficiency Virus
14.4.7 Others
14.5 Historic and Forecasted Market Size By Application
14.5.1 Hospitals
14.5.2 Commercial/Private Labs
14.5.3 Physician Offices
14.5.4 Public Health Labs
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Sexually Transmitted Diseases (STD) Testing Scope:
|
Report Data
|
Sexually Transmitted Diseases (STD) Testing Market
|
|
Sexually Transmitted Diseases (STD) Testing Market Size in 2025
|
USD XX million
|
|
Sexually Transmitted Diseases (STD) Testing CAGR 2025 - 2032
|
XX%
|
|
Sexually Transmitted Diseases (STD) Testing Base Year
|
2024
|
|
Sexually Transmitted Diseases (STD) Testing Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Lonza, Cepheid, ELITechGroup, Abbott, Affymetrix, Bio-Rad, DiaSorin, bioMerieux, Eiken Chemical, Becton Dickinson, Siemens Healthineers, GSK Biologicals.
|
|
Key Segments
|
By Type
Chlamydia Syphilis Gonorrhea Herpes Simplex Virus Human Papilloma Virus Human Immunodeficiency Virus Others
By Applications
Hospitals Commercial/Private Labs Physician Offices Public Health Labs
|